Diffuse Lung Diseases Clinical Features Pathology

Medscape: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

Lung immune diseases have become a major global public health burden, with incidence increasing over the past two decades—especially in industrialized ...

Diffuse Lung Diseases Clinical Features Pathology 3

Duncan Banner: Health - Rare Lung Diseases: What to know for earlier diagnosis and treatment

Rare lung diseases affect people nationwide, yet many patients go undiagnosed or misdiagnosed for years. One rare lung disease that illustrates the challenges of timely diagnosis is autoimmune pulmona ...

Health - Rare Lung Diseases: What to know for earlier diagnosis and treatment

phillyvoice.com: Advancing pulmonary care: how clinical trials at Temple Lung Center are shaping the future

Diffuse Lung Diseases Clinical Features Pathology 7

The treatments of tomorrow often start as clinical trials today. And when it comes to groundbreaking advancements in pulmonary care, the Temple Lung Center is at the forefront, offering patients ...

Advancing pulmonary care: how clinical trials at Temple Lung Center are shaping the future

Diffuse Lung Diseases Clinical Features Pathology 9

Clinical course of sarcoidosis in dependence on HLA-DRB1 allele frequencies, inflammatory markers, and the presence of M. tuberculosis DNA fragments. Relationship between basal thinning of the ...

EurekAlert!: A deep learning pathomics platform may help predict response to immunotherapy in lung cancer patients

A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to immunotherapy in patients with metastatic non-small cell lung ...

Diffuse Lung Diseases Clinical Features Pathology 12

A deep learning pathomics platform may help predict response to immunotherapy in lung cancer patients